US 10941184
Cell-penetrating compstatin analogs and uses thereof
granted A61KA61K38/00A61K47/645
Quick answer
US patent 10941184 (Cell-penetrating compstatin analogs and uses thereof) held by Apellis Pharmaceuticals, Inc. expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61K47/645